Whitney Ijem

Stock Analyst at Canaccord Genuity

(0.78)
# 2314
Out of 5,356 analysts
111
Total ratings
36.76%
Success rate
-7.89%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
TSHA Taysha Gene Therapie...
Maintains: Strong Buy
9 11
2.89 280.62% 10 Jun 3, 2025
RCKT Rocket Pharmaceutica...
Maintains: Buy
34 11
2.78 295.68% 8 Jun 3, 2025
NTLA Intellia Therapeutic...
Maintains: Buy
74 54
7.58 612.4% 6 Jun 3, 2025
PVLA Palvella Therapeutic...
Maintains: Buy
53 52
23.57 120.62% 3 May 16, 2025
ARCT Arcturus Therapeutic...
Maintains: Buy
68 66
11.9 454.62% 6 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
28 11
8.11 35.64% 6 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
32 39
5.72 581.82% 5 Apr 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
81 92
66.23 38.91% 7 Apr 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
385 390
307.9 26.66% 8 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
0.37 2332.43% 2 Mar 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 6
0.54 1011.11% 6 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
121 136
36.89 268.66% 8 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Hold
408 424
443.61 -4.42% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
13 13
0.43 2923.26% 6 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
148 150
39.13 283.34% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
93 84
55.28 51.95% 8 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
6 30
n/a n/a 2 Jul 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
260
n/a n/a 1 Feb 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
120 240
4.27 5520.61% 4 Jul 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
33 0
n/a n/a 2 Feb 26, 2018